Browse 14081 Federal Education Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Education grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 7th, 2028 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| November 12th, 2027 |
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 17th, 2025 |
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| December 16th, 2024 |
2026 William D. Clarke, Sr. Diplomatic Security Fellowship |
Bureau of Human Resources |
| May 4th, 2028 |
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) |
National Institutes of Health |
| February 8th, 2027 |
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2027 |
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 5th, 2026 |
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional) |
National Institutes of Health |
| June 22nd, 2026 |
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional) |
National Institutes of Health |
| June 1st, 2025 |
Transatlantic Partnership Program |
U.S. Mission to Germany |
| January 7th, 2027 |
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2027 |
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) |
National Institutes of Health |
| May 7th, 2025 |
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2027 |
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2028 |
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
National Institutes of Health |
| November 21st, 2024 |
DJIBOUTI MIDDLE SCHOOL EDUCATION ACTIVITY |
Ethiopia USAID-Addis Ababa |
|
| January 7th, 2027 |
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2027 |
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2027 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2026 |
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 7th, 2025 |
Institute of Education Sciences (IES): National Center for Education Research (NCER): Research Training Programs in The Education Sciences, Assistance Listing Number (ALN) 84.305B |
Department of Education |
| September 7th, 2026 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2028 |
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 27th, 2025 |
Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
| March 6th, 2025 |
Office of Special Education and Rehabilitative Services (OSERS): Rehabilitation Services Administration (RSA: American Indian Vocational Rehabilitation Services (AIVRS), Assistance Listing Number (ALN): 84.250R |
Department of Education |
| September 28th, 2026 |
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
National Institutes of Health |
| September 28th, 2026 |
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| October 25th, 2027 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) |
National Institutes of Health |
| October 25th, 2027 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) |
National Institutes of Health |
| February 19th, 2025 |
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional) |
National Institutes of Health |
| February 19th, 2025 |
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional) |
National Institutes of Health |
| July 1st, 2025 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
National Institutes of Health |
| June 2nd, 2027 |
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) |
National Institutes of Health |
